Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CureVac stock logo
CVAC
CureVac
$2.86
-4.0%
$3.15
$2.22
$5.28
$640.30M2.48812,111 shs401,106 shs
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$0.63
+0.8%
$1.10
$0.55
$3.38
$13.91M1.97154,526 shs37,029 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CureVac stock logo
CVAC
CureVac
+9.56%+4.20%+2.05%-29.55%+0.34%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
+4.87%-17.82%-31.02%-66.76%-33.48%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CureVac stock logo
CVAC
CureVac
3.4979 of 5 stars
3.22.00.04.81.90.01.3
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
2.6754 of 5 stars
0.05.02.50.01.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CureVac stock logo
CVAC
CureVac
2.33
Hold$10.00249.65% Upside
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest HTCR and CVAC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/14/2025
CureVac stock logo
CVAC
CureVac
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$16.00 ➝ $16.00
(Data available from 4/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CureVac stock logo
CVAC
CureVac
$543.28M1.18N/AN/A$2.50 per share1.14
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$30.41M0.46N/AN/A$0.37 per share1.70
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CureVac stock logo
CVAC
CureVac
-$281.58M$0.555.20N/AN/A20.72%21.98%15.72%4/23/2025 (Estimated)
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
-$4.19M-$0.062.633.94N/A16.25%65.33%22.92%4/14/2025 (Estimated)

Latest HTCR and CVAC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2025Q4 2024
CureVac stock logo
CVAC
CureVac
$0.27N/AN/AN/A$20.58 millionN/A
4/14/2025N/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$0.05N/AN/AN/AN/AN/A
3/31/2025Q4 2024
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$0.04-$0.17-$0.21-$0.44$4.73 million$3.44 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CureVac stock logo
CVAC
CureVac
N/AN/AN/AN/AN/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$0.046.35%N/AN/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CureVac stock logo
CVAC
CureVac
0.05
6.20
6.19
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
0.10
1.88
1.88

Institutional Ownership

CompanyInstitutional Ownership
CureVac stock logo
CVAC
CureVac
17.26%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
1.71%

Insider Ownership

CompanyInsider Ownership
CureVac stock logo
CVAC
CureVac
2.15%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
64.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
CureVac stock logo
CVAC
CureVac
880223.88 million219.07 millionOptionable
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
4022.08 million7.49 millionNot Optionable

Recent News About These Companies

HeartCore Enterprises enters partnership with NEC Solution Innovators
Q2 EPS Forecast for HeartCore Enterprises Lowered by Analyst
Q3 EPS Estimate for HeartCore Enterprises Lowered by Analyst
HeartCore Enterprises reports FY24 EPS (7c) vs. (21c) last year
HeartCore Reports 2024 Financial Results
HeartCore forms key governance committees
HeartCore Ekes Higher on Korean Expansion
HeartCore Enterprises expands Go IPO consulting services into South Korea

New MarketBeat Followers Over Time

Media Sentiment Over Time

CureVac stock logo

CureVac NASDAQ:CVAC

$2.86 -0.12 (-4.03%)
Closing price 04:00 PM Eastern
Extended Trading
$2.95 +0.09 (+3.29%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

HeartCore Enterprises stock logo

HeartCore Enterprises NASDAQ:HTCR

$0.63 +0.01 (+0.80%)
Closing price 03:59 PM Eastern
Extended Trading
$0.66 +0.03 (+5.40%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HeartCore Enterprises, Inc., a software development company, provides Software as a Service solutions to enterprise customers in Japan and internationally. Its customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. The company also operates a digital transformation business that offers customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises. In addition, it provides consulting services; and education, services, and support solutions. The company was founded in 2009 and is headquartered in Tokyo, Japan.